Salvato in:
| Autori principali: | Xiaoli Zhu, Zhuolin Jia, Ye Zhou, Jie Wu, Mayijie Cao, Changjiang Hu, Lingying Yu, Zhimin Chen |
|---|---|
| Natura: | Artículo Open Access |
| Pubblicazione: |
Wiley
2024
|
| Soggetti: | |
| Accesso online: | https://onlinelibrary.wiley.com/doi/10.1002/ptr.8259 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
Documenti analoghi
Metabolomics‐Driven Integration of Traditional Chinese Medicine for Neurological Disorders: From Precision Diagnosis to Therapeutic Innovation
di: Dongmei Mai, et al.
Pubblicazione: (2026)
di: Dongmei Mai, et al.
Pubblicazione: (2026)
Treatment of Insomnia With Traditional Chinese Medicine Presents a Promising Prospect
di: Boyi Zhang, et al.
Pubblicazione: (2025)
di: Boyi Zhang, et al.
Pubblicazione: (2025)
The Nexus Between Traditional Chinese Medicine and Immunoporosis: Implications in the Treatment and Management of Osteoporosis
di: Xiaolei Ding, et al.
Pubblicazione: (2024)
di: Xiaolei Ding, et al.
Pubblicazione: (2024)
Progress of Exosomal MicroRNAs and Traditional Chinese Medicine Monomers in Neurodegenerative Diseases
di: Jinping Liang, et al.
Pubblicazione: (2024)
di: Jinping Liang, et al.
Pubblicazione: (2024)
Traditional Chinese Medicine Improves the Development of Vascular Thrombotic Inflammation: The Key Role of Gut Microbiota and Its Derived Metabolites
di: Jingjing Xu, et al.
Pubblicazione: (2025)
di: Jingjing Xu, et al.
Pubblicazione: (2025)
Compounds of Plant Origin: The Blue Ocean of Anti‐Helicobacter pylori Medicines
di: Huimin Wu, et al.
Pubblicazione: (2025)
di: Huimin Wu, et al.
Pubblicazione: (2025)
Treatment of neuropathic pain by traditional Chinese medicine: An updated review on their effect and putative mechanisms of action
di: Wenjing Guo, et al.
Pubblicazione: (2024)
di: Wenjing Guo, et al.
Pubblicazione: (2024)
Recent Advances in the Investigation of the Role and Immunoregulatory Mechanisms of Polysaccharides From Traditional Chinese Medicine in the Intervention of Liver Cirrhosis
di: Hemiao Cui, et al.
Pubblicazione: (2025)
di: Hemiao Cui, et al.
Pubblicazione: (2025)
Mitophagy and Mitochondrial Function Regulation by Traditional Chinese Medicine Small Molecules in Cancer Therapy: Mechanisms, Challenges, and Translational Opportunities
di: Zixuan Shi, et al.
Pubblicazione: (2026)
di: Zixuan Shi, et al.
Pubblicazione: (2026)
Underlying Mechanisms of Lung Endothelial Cell Involvement in Inflammatory Immune Response in Lung Diseases and Potential Traditional Chinese Medicine: A Review
di: Liyue Ren, et al.
Pubblicazione: (2025)
di: Liyue Ren, et al.
Pubblicazione: (2025)
Traditional Chinese medicine for gastric cancer: An evidence mapping
di: Zelei Dai, et al.
Pubblicazione: (2024)
di: Zelei Dai, et al.
Pubblicazione: (2024)
Modern Research on Traditional Chinese Ethnomedicines for Rheumatoid Arthritis: Acting Through Signaling Pathways
di: Bojun Tang, et al.
Pubblicazione: (2026)
di: Bojun Tang, et al.
Pubblicazione: (2026)
Therapeutic Potential of Chinese Herbal Medicine and Underlying Mechanism for the Treatment of Myocardial Infarction
di: Jiaojiao Pan, et al.
Pubblicazione: (2024)
di: Jiaojiao Pan, et al.
Pubblicazione: (2024)
Chinese Herbal Medicine and Their Active Ingredients Involved in the Treatment of Atopic Dermatitis Related Signaling Pathways
di: Wenkai Nie, et al.
Pubblicazione: (2025)
di: Wenkai Nie, et al.
Pubblicazione: (2025)
The interplay of exercise and polyphenols in cancer treatment: A focus on oxidative stress and antioxidant mechanisms
di: Yubing Wang
Pubblicazione: (2024)
di: Yubing Wang
Pubblicazione: (2024)
Neutrophil extracellular traps: Potential targets for the treatment of rheumatoid arthritis with traditional Chinese medicine and natural products
di: Yuan Liu, et al.
Pubblicazione: (2024)
di: Yuan Liu, et al.
Pubblicazione: (2024)
New horizons for the study of saffron (Crocus sativus L.) and its active ingredients in the management of neurological and psychiatric disorders: A systematic review of clinical evidence and mechanisms
di: Shufen Han, et al.
Pubblicazione: (2024)
di: Shufen Han, et al.
Pubblicazione: (2024)
Phytochemicals targeting ferroptosis in cardiovascular diseases: Recent advances and therapeutic perspectives
di: Jianxia Wen, et al.
Pubblicazione: (2024)
di: Jianxia Wen, et al.
Pubblicazione: (2024)
Trends and Patterns for the Use of Herbal Medicinal Products for Gynaecological Ailments
di: Alexandra Drebka, et al.
Pubblicazione: (2026)
di: Alexandra Drebka, et al.
Pubblicazione: (2026)
D‐pinitol alleviates diabetic cardiomyopathy by inhibiting the optineurin‐mediated endoplasmic reticulum stress and glycophagy signaling pathway
di: Xiaoli Li, et al.
Pubblicazione: (2024)
di: Xiaoli Li, et al.
Pubblicazione: (2024)
Scutellarein alleviates osteoarthritis progression through the PI3K/Akt/NF‐kappaB signaling pathway: In vitro and in vivo studies
di: Ziyang Ye, et al.
Pubblicazione: (2024)
di: Ziyang Ye, et al.
Pubblicazione: (2024)
The Role of Medicinal Plants in Modulating Epigenetic Mechanisms: Implications for Cancer Prevention and Therapy
di: Khadra Afaf Bendrihem, et al.
Pubblicazione: (2025)
di: Khadra Afaf Bendrihem, et al.
Pubblicazione: (2025)
Diosmetin as a promising natural therapeutic agent: In vivo, in vitro mechanisms, and clinical studies
di: Zihao Sun, et al.
Pubblicazione: (2024)
di: Zihao Sun, et al.
Pubblicazione: (2024)
Blueberry extract for the treatment of ischaemic stroke through regulating the gut microbiota and kynurenine metabolism
di: Raoqiong Wang, et al.
Pubblicazione: (2024)
di: Raoqiong Wang, et al.
Pubblicazione: (2024)
Unlocking the Potential of Phyllanthus Species From Traditional Knowledge to Clinical Trials: An Updated Review of Metabolomics Approach in Diabetes Intervention
di: Pei Lou Wong, et al.
Pubblicazione: (2026)
di: Pei Lou Wong, et al.
Pubblicazione: (2026)
Topical and transdermal botanical formulations of the Chinese pharmacopoeia—A review
di: Jingyi Gu, et al.
Pubblicazione: (2024)
di: Jingyi Gu, et al.
Pubblicazione: (2024)
Magnoliae flos Overcomes EGFR ‐ TKI Resistance in NSCLC by Enhancing EGFR Ubiquitination
di: Qing Wu, et al.
Pubblicazione: (2026)
di: Qing Wu, et al.
Pubblicazione: (2026)
Isorhyncophylline Targets PP2AC to Modulate YAP to Inhibit Endothelial Cell Inflammation
di: Lihua Wang, et al.
Pubblicazione: (2026)
di: Lihua Wang, et al.
Pubblicazione: (2026)
Epigenetic Effects of Natural Products in Inflammatory Diseases: Recent Findings
di: Qianyi Yao, et al.
Pubblicazione: (2024)
di: Qianyi Yao, et al.
Pubblicazione: (2024)
Targeting Programmed Cell Death in Myocardial Ischemia–Reperfusion Injury: Potential Mechanisms and Natural Medicine Treatments
di: Xiaoyu Xuan, et al.
Pubblicazione: (2026)
di: Xiaoyu Xuan, et al.
Pubblicazione: (2026)
Costunolide Ameliorates Hepatic Steatosis and Insulin Resistance in a Diet‐Induced Mouse Model of Metabolic Dysfunction‐Associated Steatotic Liver Disease by Activating the AMPK / ACC1 Signalling Pathway
di: Wen Jiang, et al.
Pubblicazione: (2026)
di: Wen Jiang, et al.
Pubblicazione: (2026)
Comments on: Unveiling the therapeutic promise of natural products in alleviating drug‐induced liver injury: Present advancements and future prospects
di: Hartmut Jaeschke, et al.
Pubblicazione: (2024)
di: Hartmut Jaeschke, et al.
Pubblicazione: (2024)
A Natural LDHA Allosteric Inhibitor Geraniin Suppresses Triple‐Negative Breast Cancer Cell Growth
di: Yan Yu, et al.
Pubblicazione: (2025)
di: Yan Yu, et al.
Pubblicazione: (2025)
Osthole accelerates osteoporotic fracture healing by inducing the osteogenesis–angiogenesis coupling of BMSCs via the Wnt/β‐catenin pathway
di: Sheng Zheng, et al.
Pubblicazione: (2024)
di: Sheng Zheng, et al.
Pubblicazione: (2024)
Modulation of atherosclerosis‐related signaling pathways by Chinese herbal extracts: Recent evidence and perspectives
di: Changxing Liu, et al.
Pubblicazione: (2024)
di: Changxing Liu, et al.
Pubblicazione: (2024)
Astragaloside IV Exhibited Antidiabetic Effects by Improving Glucose Metabolism, Repairing Damaged Gut Barrier and Regulating Intestinal Microbiota
di: Xiaolei Yang, et al.
Pubblicazione: (2026)
di: Xiaolei Yang, et al.
Pubblicazione: (2026)
Asiatic Acid Ameliorates MNNG ‐Induced Chronic Atrophic Gastritis by Inhibiting the Activation of the HRAS / PI3K / AKT / GSK3β Signaling Axis
di: Feifei Zhou, et al.
Pubblicazione: (2026)
di: Feifei Zhou, et al.
Pubblicazione: (2026)
The health benefits of dietary polyphenols on pediatric intestinal diseases: Mechanism of action, clinical evidence and future research progress
di: Yu‐Rou Jiang, et al.
Pubblicazione: (2024)
di: Yu‐Rou Jiang, et al.
Pubblicazione: (2024)
Resveratrol Attenuates Neuroinflammation and Gut–Brain Axis Dysfunction Induced by Lead and Cadmium Co‐Exposure by Modulating Gut Microbiota in Rats
di: Huimao Liu, et al.
Pubblicazione: (2026)
di: Huimao Liu, et al.
Pubblicazione: (2026)
Targeting programmed cell death in inflammatory bowel disease through natural products: New insights from molecular mechanisms to targeted therapies
di: Mengjie Wang, et al.
Pubblicazione: (2024)
di: Mengjie Wang, et al.
Pubblicazione: (2024)
Documenti analoghi
-
Metabolomics‐Driven Integration of Traditional Chinese Medicine for Neurological Disorders: From Precision Diagnosis to Therapeutic Innovation
di: Dongmei Mai, et al.
Pubblicazione: (2026) -
Treatment of Insomnia With Traditional Chinese Medicine Presents a Promising Prospect
di: Boyi Zhang, et al.
Pubblicazione: (2025) -
The Nexus Between Traditional Chinese Medicine and Immunoporosis: Implications in the Treatment and Management of Osteoporosis
di: Xiaolei Ding, et al.
Pubblicazione: (2024) -
Progress of Exosomal MicroRNAs and Traditional Chinese Medicine Monomers in Neurodegenerative Diseases
di: Jinping Liang, et al.
Pubblicazione: (2024) -
Traditional Chinese Medicine Improves the Development of Vascular Thrombotic Inflammation: The Key Role of Gut Microbiota and Its Derived Metabolites
di: Jingjing Xu, et al.
Pubblicazione: (2025)